H.R. 4121

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Sponsor: Andy Harris · 0 cosponsors

Follow this bill

Official summary

Written by the Congressional Research Service.

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

This bill provides FY2026 appropriations for the Department of Agriculture (USDA), the Food and Drug Administration, and related agencies.

The bill provides appropriations to USDA for agricultural programs, including

  • the Office of the Secretary,
  • Executive Operations,
  • the Economic Research Service,
  • the National Agricultural Statistics Service,
  • the Agricultural Research Service,
  • the National Institute of Food and Agriculture,
  • the Animal and Plant Health Inspection Service,
  • the Agricultural Marketing Service, and
  • the Food Safety and Inspection Service.

The bill also provides appropriations to USDA for farm production and conservation programs, including

  • the Farm Production and Conservation Business Center,
  • the Farm Service Agency,
  • the Risk Management Agency, and
  • the Natural Resources Conservation Service.

The bill provides appropriations to the Federal Crop Insurance Corporation Fund and the Commodity Credit Corporation Fund.

For USDA rural development programs, the bill includes appropriations for

  • Salaries and Expenses,
  • the Rural Housing Service,
  • the Rural Business-Cooperative Service, and
  • the Rural Utilities Service.

The bill provides appropriations to the Food and Nutrition Service for

  • Child Nutrition Programs;
  • the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC);
  • the Supplemental Nutrition Assistance Program (SNAP);
  • the Commodity Assistance Program; and
  • Nutrition Programs Administration.

The bill provides appropriations to the Foreign Agricultural Service for (1) Food for Peace Title II Grants, and (2) McGovern-Dole International Food for Education and Child Nutrition Program Grants.

The bill also provides appropriations for

  • the Food and Drug Administration,
  • the Commodity Futures Trading Commission, and
  • the Farm Credit Administration.

Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations acts.

Text of the bill

Expand all

I AGRICULTURAL PROGRAMS

II

III RURAL DEVELOPMENT PROGRAMS

IV

V FOREIGN ASSISTANCE AND RELATED PROGRAMS

VI

VII GENERAL PROVISIONS

Sec. 766.

No funds appropriated by this Act may be used to implement, administer, or enforce the "Requirements for Additional Traceability Records for Certain Foods" published on November 21, 2022 (87 Fed. Reg. 70910), or any other rule promulgated in accordance with section 204 of the FDA Food Safety Modernization Act (21 U.S.C. 2223), prior to August 1, 2028, and until the U.S. Food and Drug Administration:

(1) completes at least 4 evaluations or beta tests using multiple products on the Food Traceability List, in coordination with farms and with food industry members operating restaurants, retail food establishments, FDA registered food facilities, food packing facilities and warehouses distributing to retail food establishments, and restaurants, to—

(A) identify and test low-cost food traceability technologies that track both the traceability lot code and traceability lot code source throughout the global supply chain and evaluate the effectiveness of these technologies and their economic feasibility for various sized operations throughout the supply chain; and

(B) facilitate interoperability by assessing industry standards and establishing a model data format along with reusable templates that allow diverse systems to communicate, share, and use traceability data effectively;

(2) establishes a panel of experts to assess the FDA’s foodborne illness traceback investigation process, for both foreign and domestic food suppliers, and to provide feedback for the evaluations or beta tests. This panel shall include diverse stakeholders, such as retailers, distributors, growers, state and local officials, and public health officials. The FDA shall publish the panel outcomes and recommendations no later than one year from the date of enactment of this Act.